Efficacy and safety of Naga Bhasma and Nisha-Amalaki Churna in the management of Madhumeha (type 2 diabetes) - A double-blind, randomized, controlled clinical trial
Taviad Krushnakumar, Makwana Sarika, Bedarkar Prashant, BJ Patgiri- General Medicine
Abstract
Background:
Increasing global incidence of diabetes is a serious issue and large number of researches are undergoing to find promising cure of this chronic disease. Many Ayurveda drugs have been evaluated for anti-diabetic properties; however, researches on metallic/mineral based drugs are very few. The present study aimed to assess the comparative efficacy and safety of
Materials and methods:
In this prospective, randomized, double blind, active controlled study; 132 patients with type 2 diabetes were included and randomly divided into four groups. Patients were treated with NAC (125 mg) with placebo (roasted
Results:
After 90 days of medication, fasting and postprandial blood glucose levels and clinical symptoms in three groups were significantly decreased when compared with baseline except NAC group. Hemogram and hepatic and renal profiles (safety parameters) in the four groups were not significantly different from the baseline. No adverse events were reported with the use of the studied medicine.
Conclusion:
SNB along with NAC possessed more symptomatic relief in comparison to TNB with NAC, NAC alone and Metformin thereby improving the quality of life of patients along with significant glycemic control and free from any significant side effects.